Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion.

Patel, Palak N; Dickey, Thayne H; Hopp, Christine S; Diouf, Ababacar; Tang, Wai Kwan; Long, Carole A; Miura, Kazutoyo; Crompton, Peter D; Tolia, Niraj H

Patel, Palak N; Dickey, Thayne H; Hopp, Christine S; Diouf, Ababacar; Tang, Wai Kwan; Long, Carole A; Miura, Kazutoyo; Crompton, Peter D; Tolia, Niraj H.

Afiliación

Patel PN; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Dickey TH; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Hopp CS; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Diouf A; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Tang WK; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Long CA; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Miura K; Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Crompton PD; Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Tolia NH; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. niraj.tolia@nih.gov.

Nat Commun ; 13(1): 5888, 2022 10 06.

Article en En | MEDLINE | ID: mdl-36202833

Asunto(s)

Vacunas contra la Malaria; Proteína 1 de Superficie de Merozoito; Anticuerpos Bloqueadores; Anticuerpos Monoclonales; Anticuerpos Neutralizantes; Antígenos de Protozoos; Epítopos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la Malaria / Proteína 1 de Superficie de Merozoito Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google